Pharmacovigilance Research Report

Transforming Pharmacovigilance

Survey report on PV outsourcing trends

Read the new industry research report “Optimizing End-To-End Safety In Clinical Development With Combined PV Solutions” highlighting how pharma and biotech companies are optimizing their approach to PV. Findings include:

PV strategy (40%), PV technology/database (38%) and Compliance management (34%) are the PV operations outsourced most.
Data security (45%), Cost (44%), Efficiency (42%) and Accuracy (33%) are the top considerations when selecting PV technology.
89% of pharma companies plan to outsource to vendors that combine PV services with technology

LET’S TALK

Go beyond the download: request a consultation with a dedicated sales specialist.

First Name*

Last Name*

Email Address*

Title*

Company*

Country*

Please provide us with more detail of your need.*

Opt In

By selecting this box, I consent to receiving marketing communications and information about IQVIA's offering by email.

address1